🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

8,395 results for “La” Clear

  1. Tramadol HCI/acetaminophen

    Janssen-Cilag Pty Ltd

    Cancer

    approved small molecule completed

    1 trial

  2. Trangorex 200 mg comprimidos

    The George Institute

    Atrial fibrillation

    approved small molecule active

    1 trial

  3. Transepicardial with Transseptal CD 133+ Implantation

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved mab completed

    1 trial

  4. Trelagliptin

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  5. Trelagliptin

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    2 trials

  6. Triamcinolone acetonide-Ketorolac-Ropivacaine

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    approved small molecule active

    1 trial

  7. USTEKINUMAB, USTEKINUMAB, deucravacitinib

    Bristol-Myers Squibb Australia Pty Ltd

    Moderate to Severe Plaque Psoriasis

    approved small molecule active

    1 trial

  8. Use of Mitomycin-C (MMC) in trabeculectomy

    AEON Biopharma

    Glaucoma

    approved small molecule completed

    1 trial

  9. Use of an Implantable Loop Recorder

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial

  10. VENLAFAXINE

    Disc Medicine

    Major Depressive Disorder

    approved small molecule active

    1 trial

  11. VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg

    Pfizer Australia Pty Ltd

    Migraine attacks with or without aura

    approved small molecule active

    1 trial

  12. Vabysmo 120 mg/mL solution for injection

    Hoffmann-La Roche

    Neovascular Age-Related Macular Degeneration

    approved small molecule active

    1 trial

  13. Vaicella Vaccine+DTaP on Day 0, MMR on Day 30

    Sinovac Research and Development Co.,

    Varicella (chickenpox)

    approved mab active

    1 trial

  14. Varicella vaccine

    Sinovac Research and Development Co.,

    VZV

    approved mab completed

    1 trial

  15. Varicella vaccine+TIV

    Sinovac Research and Development Co.,

    Varicella

    approved mab completed

    1 trial

  16. Vedolizumab Placebo

    Takeda

    Pouchitis

    approved small molecule completed

    1 trial

  17. Velaglucerase Alfa

    Takeda

    Gaucher Disease

    approved small molecule completed

    4 trials

  18. Vemurafenib

    Hoffmann-La Roche

    Neoplasms

    approved small molecule completed

    1 trial

  19. Venetoclax

    AbbVie

    Acute Myeloid Leukemia (AML)

    approved small molecule active

    1 trial

  20. Vortioxetine

    Takeda

    Unipolar Major Depression

    approved small molecule terminated

    1 trial

  21. Vortioxetine 10 mg

    Takeda

    Age-related Cognitive Decline

    approved small molecule completed

    1 trial

  22. Vyvanse (lisdexamfetamine dimesylate)

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  23. Warfarin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anticoagulation

    approved small molecule active

    1 trial

  24. Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen

    Lacuna Pharma Pty Ltd

    Adipositas

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources